EN
HI
Summary
As of 14 Sep, 2026, Suven Life Sciences stock price is ₹355.55. During the trading session, the stock has moved between an intraday low of ₹351.50 and an intraday high of ₹359.95. Over the last 52 weeks, Suven Life Sciences has traded between ₹124.11 and ₹403.35.
The stock has recorded a trading volume of 3,69,913 shares,. Its Average Traded Price (ATP) is ₹354.69, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 25 @ ₹355.55.
Suven Life Sciences has an upper circuit limit of ₹426.65 and a lower circuit limit of ₹284.45. The total value traded stands at ₹13.12 CR, and the delivery percentage for the day is 55.45%.
The stock is currently traded with a market lot size of 1. Suven Life Sciences also offers a dividend yield of 0%.
Suven Life Sciences Share Price Chart
Suven Life Sciences Share Key Metrics
Volume
3.70 L
Market Cap
10046.52 CR
LTQ@LTP
25@355.55
ATP
354.69
Var Margin
100 %
Circuit Range
284.45-426.65
Delivery %
55.45 %
Value
13.12 CR
ASM/GSM
No
Market Lot
1
Suven Life Sciences Fundamentals
P/E Ratio
0
P/B Ratio
18
Div. Yield
0
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Suven Life Sciences Resistance and Support
Pivot 355.67
Resistance
First Resistance
359.84
Second Resistance
364.12
Third Resistance
368.29
Support
First Support
351.39
Second Support
347.22
Third Support
342.94
Suven Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 355 | 355.54 | -1.43% | 359.95 | 351.5 |
| Thu Sep 10 2026 | 357.75 | 360.7 | 0.90% | 366.7 | 357.75 |
| Wed Sep 09 2026 | 369.89 | 357.5 | -3.35% | 376.75 | 355.04 |
Suven Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-13 | Audited Results |
| 2026-01-29 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-13 | Audited Results & Preferential issue |
| 2025-01-24 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Suven Life Sciences News
Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences completed patient enrollment in its global Phase-3 clinical study of Masupirdine (SUVN-502) for Agitation Associated with Alzheimer's Dementia (AAD). A total of 424 patients were randomized, exceeding the target of 375 patients. Topline results are expected by May 2027.
Sep 03 2026 11:56:31
Suven Life Sciences Management
| Name | Position |
|---|---|
| Venkateswarlu Jasti | Chairman & Managing Director |
| Seyed E Hasnain | Non Executive Director |
Suven Life Sciences Similar Stocks
Viyash Scientific Ltd.
257.60
0.00 (0.00%)
Sanofi Consumer Healthcare India Ltd.
4023.40
0.00 (0.00%)
Strides Pharma Science Ltd.
1183.40
0.00 (0.00%)
Blue Jet Healthcare Ltd.
568.55
0.00 (0.00%)
Healthcare Global Enterprises Ltd.
693.90
0.00 (0.00%)
Yatharth Hospital & Trauma Care Services Ltd.
966.30
0.00 (0.00%)
Jupiter Life Line Hospitals Ltd.
279.15
0.00 (0.00%)
Thyrocare Technologies Ltd.
549.70
0.00 (0.00%)
Procter & Gamble Health Ltd.
5411.50
0.00 (0.00%)
Nephrocare Health Services Ltd.
765.35
0.00 (0.00%)
Suven Life Sciences FAQs
The Buying Price of Suven Life Sciences share is 355.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Suven Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Suven Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Suven Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Suven Life Sciences shares is 18. Useful to assess the stock's value relative to its book value.
To assess Suven Life Sciences’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Suven Life Sciences is 10046.52 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Suven Life Sciences share price is 403.35 & 124.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Suven Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SUVEN
